NCT04869475 2021-05-13Arsenic Trioxide in Refractory Solid Tumors With Rescuable p53 MutationRuijin HospitalPhase 2 Unknown20 enrolled
NCT00404508 2006-11-28A Phase II Study of Epigenetic Therapy to Overcome Chemotherapy Resistance in Refractory Solid TumorsNational Institute of CancerologíaPhase 2 Completed15 enrolled